The use of synthetic images could reduce the amount of gadolinium-based contrast agents needed for breast MRI examinations, according to new data published this week in Radiology. 

Preoperative ultrafast MRI could help guide biopsy and surgical management decision in patients with ductal carcinoma in situ. 

Prior research has shown that not only is contrast-enhanced spectral mammography comparable to CE-MRI in accuracy of loco-regional staging, but some studies have even found it to perform better.

These trends include growth in 3D mammography, supplemental imaging for women with dense breasts and in the role of artificial intelligence.

The modality outperformed digital breast tomosynthesis, handheld ultrasound and automated breast ultrasound for cancer detection in a large cohort of women with dense breast tissue.

Prior to 2018, it was recommended that women at higher-than-average risk undergo supplemental breast MRI screening only if they had a personal history of breast cancer in addition to carrying a hereditary breast cancer gene mutation.

JoAnn Pushkin, breast cancer survivor and executive director of DenseBreast-info.org, sounded the alarm on the lack of awareness surrounding breast density and its associated cancer risks during a presentation at this year’s annual RSNA meeting.

Synthesizing contrast-enhanced imaging from pre-contrast inputs using deep learning can help overcome obstacles involved in the use of GBCAs.